Quantcast
Are you getting the best rate from your broker?
Compare your broker's rates now to find out if you can save money

Choose your broker below
Welcome to Dividend.com. Please help us personalize your experience.

Select the one that best describes you
ALERT

Strong Defense Leads to 25% Gain for Best Dividend Aerospace Pick

Dividend logo

Gilead Sciences, Inc. (GILD ) is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines. The company’s primary areas of focus are immunodeficiency virus (HIV), liver diseases, such as chronic hepatitis C virus (HCV) and chronic hepatitis B virus (HBV), oncology and inflammation, and serious cardiovascular and respiratory conditions. The company has two high-profile treatments: Harvoni and Sovaldi. These two drugs accounted for nearly 60% of the company’s revenue in both quarters of 2015.

Additionally, Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands approximately 75% of the U.S. treatment market and more than 50% worldwide.

Gilead Sciences recently started paying a quarterly dividend of $0.43 per share. Its first payout was on 6/29/2015. It’s going Ex-Dividend again on 9/14/2015. Its annual payout comes to $1.72, yielding 1.50% on its current price of $114.

To read the Full Story, Go Premium or Log In

Popular Articles

Premium Shutterstock 389143408
News

Fidelity’s Six Successful Investor Habits

When it comes to retirement investing, long-term success is about 70/30. The thirty percent is...

News

Should Home Depot Be Your Exposure to the U.S. Housing Market?

Home Depot (HD ) is “just” 39 years old and yet is the biggest home improvement retailer in the...

Premium Shutterstock 230306104
News

Will Subprime Loans Take the Auto Industry Down?

The last few years have been pretty good for the automakers. Many consumers had put off buying...